BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24939416)

  • 1. CYP1A1 Ile462Val polymorphism and colorectal cancer risk in Polish patients.
    Gil J; Gaj P; Misiak B; Ostrowski J; Karpinski P; Jarczyńska A; Kielan W; Sasiadek MM
    Med Oncol; 2014 Jul; 31(7):72. PubMed ID: 24939416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence Polymorphism in Xenobiotic Metabolising Genes in Iraqi Colorectal Cancer Patients.
    Ibrahem SQ; Al-Dalawi ZT; Bahaaldin AS
    Asian Pac J Cancer Prev; 2021 Apr; 22(4):1203-1210. PubMed ID: 33906313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in XRCC1, ERCC2, and ERCC3 DNA repair genes, CYP1A1 xenobiotic metabolism gene, and tobacco are associated with bladder cancer susceptibility in Tunisian population.
    Feki-Tounsi M; Khlifi R; Louati I; Fourati M; Mhiri MN; Hamza-Chaffai A; Rebai A
    Environ Sci Pollut Res Int; 2017 Oct; 24(28):22476-22484. PubMed ID: 28803404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between CYP1A1 rs1048943 A > G and rs4646903 T > C genetic variations and colorectal cancer risk: Proof from 26 case-control studies.
    Zhu X; Wang Z; He J; Wang W; Xue W; Wang Y; Zheng L; Zhu ML
    Oncotarget; 2016 Aug; 7(32):51365-51374. PubMed ID: 27384991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking.
    Yoshida K; Osawa K; Kasahara M; Miyaishi A; Nakanishi K; Hayamizu S; Osawa Y; Tsutou A; Tabuchi Y; Shimada E; Tanaka K; Yamamoto M; Takahashi J
    Asian Pac J Cancer Prev; 2007; 8(3):438-44. PubMed ID: 18159984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 116G > A MSH6 and IVS1-1121C > T PMS2 Genes Polymorphisms Modulate the Risk of the Sporadic Colorectal Cancer Development in Polish Population.
    Zelga P; Przybyłowska-Sygut K; Zelga M; Dziki A; Majsterek I
    Pathol Oncol Res; 2018 Apr; 24(2):231-235. PubMed ID: 28451866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival.
    Salimzadeh H; Lindskog EB; Gustavsson B; Wettergren Y; Ljungman D
    BMC Cancer; 2020 May; 20(1):409. PubMed ID: 32397974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between dietary heterocyclic amine levels, genetic polymorphisms of NAT2, CYP1A1, and CYP1A2 and risk of colorectal cancer: a hospital-based case-control study in Japan.
    Kobayashi M; Otani T; Iwasaki M; Natsukawa S; Shaura K; Koizumi Y; Kasuga Y; Sakamoto H; Yoshida T; Tsugane S
    Scand J Gastroenterol; 2009; 44(8):952-9. PubMed ID: 19452301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between cigarette smoking and selected polymorphisms in xenobiotic metabolizing enzymes in risk for colorectal cancer: A case-only analysis.
    Pande M; Amos CI; Eng C; Frazier ML
    Mol Carcinog; 2010 Nov; 49(11):974-80. PubMed ID: 20886582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of the CYP1A1*2A Allele on Colorectal Cancer Susceptibility in a British Population.
    Öztaş E; Özhan G; Daly AK
    Genet Test Mol Biomarkers; 2016 Aug; 20(8):475-7. PubMed ID: 27243113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism association of NIL1, NIL2, CYP1A1 xenobiotic metabolism genes and their expression with the risk of colorectal cancer in the Polish population.
    Kabziński J; Gogolewska M; Nowakowski M; Kucharska E; Dziki Ł; Mik M; Dziki A; Majsterek I
    Pol Przegl Chir; 2022 Mar; 94(2):54-59. PubMed ID: 35485310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The polymorphisms of miRNA-binding site in MLH3 and ERCC1 were linked to the risk of colorectal cancer in a case-control study.
    Zhang Q; Zheng X; Li X; Sun D; Xue P; Zhang G; Xiao M; Cai Y; Jin C; Yang J; Wu S; Lu X
    Cancer Med; 2018 Apr; 7(4):1264-1274. PubMed ID: 29516665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP1A1 Ile462Val polymorphism contributes to colorectal cancer risk: a meta-analysis.
    Jin JQ; Hu YY; Niu YM; Yang GL; Wu YY; Leng WD; Xia LY
    World J Gastroenterol; 2011 Jan; 17(2):260-6. PubMed ID: 21246002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population.
    Paszkowska-Szczur K; Scott RJ; Górski B; Cybulski C; Kurzawski G; Dymerska D; Gupta S; van de Wetering T; Masojć B; Kashyap A; Gapska P; Gromowski T; Kładny J; Lubiński J; Dębniak T
    Mol Biol Rep; 2015 Mar; 42(3):755-64. PubMed ID: 25391773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms in xenobiotic clearance genes and their influence on disease expression in hereditary nonpolyposis colorectal cancer patients.
    Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2307-10. PubMed ID: 17119063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between ERCC1 Gene Polymorphism (rs11615) and Colorectal Cancer Susceptibility: A Meta-Analysis of Medical Image Fusion and Safety Applications.
    Liu M; Qiu Z; Yang Q
    Comput Math Methods Med; 2022; 2022():9988513. PubMed ID: 36277013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleotide excision repair pathway gene polymorphisms are associated with risk and prognosis of colorectal cancer.
    Li YK; Xu Q; Sun LP; Gong YH; Jing JJ; Xing CZ; Yuan Y
    World J Gastroenterol; 2020 Jan; 26(3):307-323. PubMed ID: 31988591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.
    Firozi PF; Bondy ML; Sahin AA; Chang P; Lukmanji F; Singletary ES; Hassan MM; Li D
    Carcinogenesis; 2002 Feb; 23(2):301-6. PubMed ID: 11872636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of CYP1A1, CYP2E1, GSTM3 and NAT2 genetic polymorphisms in oral cancer susceptibility: results from a case-control study in Rio de Janeiro.
    Marques CF; Koifman S; Koifman RJ; Boffetta P; Brennan P; Hatagima A
    Oral Oncol; 2006 Jul; 42(6):632-7. PubMed ID: 16488179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pooled sample-based GWAS: a cost-effective alternative for identifying colorectal and prostate cancer risk variants in the Polish population.
    Gaj P; Maryan N; Hennig EE; Ledwon JK; Paziewska A; Majewska A; Karczmarski J; Nesteruk M; Wolski J; Antoniewicz AA; Przytulski K; Rutkowski A; Teumer A; Homuth G; Starzyńska T; Regula J; Ostrowski J
    PLoS One; 2012; 7(4):e35307. PubMed ID: 22532847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.